Anuncio • May 02
Corien Wortmann, Member of the Board Is Not Eligible for Re-Election and Karen Fawcett Intends Not Stand for Re-Election for the Aegon Ltd Aegon Ltd. announced that due to reaching the end of her 12-year tenure, Ms. Corien Wortmann is not eligible for re-election. Ms. Karen Fawcett has indicated that she will not stand for re-election at the upcoming AGM. Anuncio • Apr 17
Standard Life plc (LSE:SDLF) entered into a Share Purchase Agreement to acquire AEGON UK Plc from Aegon Ltd. (ENXTAM:AGN) for £2 billion. Standard Life plc (LSE:SDLF) entered into a Share Purchase Agreement to acquire AEGON UK Plc from Aegon Ltd. (ENXTAM:AGN) for £2 billion on April 15, 2026. A cash consideration of £750 million will be paid by Standard Life plc. The consideration consists of 181.1 million common equity of Standard Life plc to be issued for common equity of AEGON UK Plc. Newly issued shares to Aegon on Completion will result in Aegon becoming a 15.3% shareholder in the enlarged group. The total consideration will be financed through - cash consideration of £750 million, financed through a combination of £650m debt issuance to be issued prior to completion and cash resources and the issuance to Aegon of 181.1 million newly issued shares, representing approximately 15.3% of the Standard Life's enlarged share capital, in Standard Life at completion of the transaction. Pursuant to a bridge facility agreement between, among others, Standard Life and BNP Paribas SA as agent, the lenders have made available a term loan facility in an aggregate principal amount of £750 million.
Pursuant to the Relationship Agreement, Aegon will have the right to appoint one non-executive director to the Board for so long as it holds 10% or more of Standard Life's voting rights.
AEGON UK reported gross assets of £110,757?million and operating profit of £190 million for year ended December 31, 2025. Completion of the Transaction under the SPA is subject to the satisfaction of conditions, including obtaining certain regulatory approvals from certain antitrust and other regulatory authorities and is expected to complete around end 2026.
Matthew Cannon, Edward Peel, James Gill, Oliver Elias and Marin Georgiev of Merrill Lynch International acted as financial advisor for Standard Life plc. Sam McLennan, Jolyon Luke, Lars Kraemer, Rory Frost and Jeremy Humphreys-Davies of BNP Paribas UK acted as financial advisor for Standard Life plc.Freshfields LLP is acting as legal adviser to Standard Life. Matt Hamilton-Foyn and Kate McInerney of Allen Overy Shearman Sterling LLP acted as the legal advisor to Aegon Ltd. Anuncio • Dec 18
Aegon Ltd. to Report First Half, 2026 Results on Aug 20, 2026 Aegon Ltd. announced that they will report first half, 2026 results on Aug 20, 2026 Anuncio • Dec 11
Aegon Ltd. Announces Dividend Growth for the Year 2025 Aegon Ltd. announced that new financial ambitions for the transition period including dividend growth of >5% per annum from around EUR 0.40 per share for 2025. Anuncio • Dec 10
Aegon Ltd. (ENXTAM:AGN) announces an Equity Buyback for €400 million worth of its shares. Aegon Ltd. (ENXTAM:AGN) announces a share repurchase program. Under the program, the company will repurchase up to €400 million worth of its shares. The program will split evenly between the first and the second half of 2026. Anuncio • Nov 28
Aegon Reportedly Eyes Sale of Non-US Units Aegon Ltd. (ENXTAM:AGN) has been assessing the option of divesting certain non-US units as it aims to focus on its US business, Bloomberg reported. According to unnamed sources cited by the news agency, the insurer has approached financial advisers. One of the businesses that may be offloaded is Aegon UK, which administers retirement accounts. Aegon may also choose to sell its 51% interest in a joint venture with Banco Santander SA. The unitoffers insurance products in Spain and Portugal. Anuncio • Nov 03
Aegon Announces Changes to Its Board of Directors, Effective from November 13, 2025 Aegon Ltd. announced that David Herzog, who was appointed as a member of the Board of Directors (BoD) at Aegon’s 2025 Annual General Meeting of shareholders (AGM), will succeed William Connelly as Chairman of the BoD as of November 13, 2025. In line with previous announcements, Mr. Connelly will retire as Chairman and member of the BoD on the same date. Anuncio • Oct 07
Aegon Ltd. to Report Second Half, 2025 Results on Feb 19, 2026 Aegon Ltd. announced that they will report second half, 2025 results on Feb 19, 2026 Anuncio • Aug 21
Aegon Ltd. Announces Interim Dividend for Year 2025 Aegon Ltd. announced interim dividend of EUR 0.19 per common share for 2025, an increase of EUR 0.03 compared with 2024 interim dividend. Anuncio • Jun 12
Aegon Ltd. Approves Final Dividend for the Year 2024 Aegon Ltd. approved final dividend for 2024 of EUR 0.19 per common share, bringing Aegon’s total dividend for 2024 to EUR 0.35 per common share. Anuncio • Apr 01
Aegon Ltd. Announces to Retire William Connelly as Chair and Member of the Board Aegon Ltd. announced the board intends to appoint David Herzog as Chair in the second half of 2025. Mr. Herzog will succeed William Connelly. Subsequently, Mr. Connelly will retire as Chair and member of the Board in the second half of 2025. Anuncio • Nov 16
Aegon Ltd., Annual General Meeting, Jun 12, 2025 Aegon Ltd., Annual General Meeting, Jun 12, 2025. Anuncio • Sep 14
Aegon Ltd. Appoints Chief Strategy, Transformation and Growth Officer and Member of Executive Committee, Effective November 1, 2024 Aegon announced the appointment of Michele Bareggi as Chief Strategy, Transformation and Growth Officer, and member of Aegons Executive Committee, starting November 1, 2024. Michele succeeds Duncan Russell, who took on the role of Group CFO in September 2024. Mr. Bareggi brings over 25 years of experience in the financial services industry, including his tenure at Athora, a leading European savings and retirement services group. Mr. Bareggi has been instrumental in establishing Athora, leading the group through a significant period of growth including its expansion into Belgium, Ireland, Italy and the Netherlands. Prior to his role at Athora, he held various positions at major global investment banks, including Morgan Stanley and Credit Suisse, covering both private and public markets. Anuncio • May 19
Aegon Announces CFO Changes Aegon announced the appointment of Duncan Russell (1978) as Chief Financial Officer (CFO), effective September 1, 2024. Duncan will succeed Matt Rider (1963), who will retire after over seven years of exceptional service to the company. Matt will continue to serve as a member of the Board of Transamerica on a non-executive basis. Duncan Russell joined Aegon as Chief Transformation Officer in 2020. Prior to Aegon, Duncan worked at UK-based Admiral Group Plc, where he last held the position of CFO of Admiral Financial Services. Prior to that, he worked for NN Group N.V., responsible for Group Capital Management, Treasury, Business Development and Group Strategy, and at J.P. Morgan as Managing Director and Head of Equity Research European Insurance. Anuncio • May 09
Aegon N.V. Proposes Final Dividend for 2023 Aegon N.V.’s proposed a final dividend for 2023 of EUR 0.16 per common share, bringing Aegon’s total dividend for 2023 to EUR 0.30 per common share. Anuncio • Mar 01
Aegon Ltd. to Report Fiscal Year 2023 Results on Apr 04, 2024 Aegon Ltd. announced that they will report fiscal year 2023 results on Apr 04, 2024 Reported Earnings • Aug 23
Second quarter 2023 earnings released: €0.14 loss per share (vs €0.023 loss in 2Q 2022) Second quarter 2023 results: €0.14 loss per share (further deteriorated from €0.023 loss in 2Q 2022). Net loss: €283.0m (loss widened €236.0m from 2Q 2022). Revenue is forecast to grow 28% p.a. on average during the next 3 years, compared to a 2.9% growth forecast for the Insurance industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 88 percentage points per year, which is a significant difference in performance. Upcoming Dividend • Aug 22
Upcoming dividend of €0.14 per share at 5.0% yield Eligible shareholders must have bought the stock before 29 August 2023. Payment date: 27 September 2023. The company is not currently making a profit but it is cash flow positive. Trailing yield: 5.0%. Within top quartile of German dividend payers (4.9%). Higher than average of industry peers (4.2%). Anuncio • Jul 07
Aegon N.V. (ENXTAM:AGN) announces an Equity Buyback for €1,500 million worth of its shares. Aegon N.V. (ENXTAM:AGN) announces a share repurchase program. Under the program, the company will repurchase up to €1,500 million worth of its shares. The repurchased shares will be cancelled. The repurchase program is expected to be completed on or before June 30, 2024. Anuncio • May 26
Aegon N.V. Approves Final Dividend for the Year 2022 Aegon N.V.’s Annual General Meeting approved all resolutions on the agenda, including the adoption of the Annual Accounts for the financial year 2022, and a final dividend for 2022 of EUR 0.12 per common share, which brings Aegon’s total dividend for 2022 to EUR 0.23 per common share. Upcoming Dividend • May 22
Upcoming dividend of €0.12 per share at 5.6% yield Eligible shareholders must have bought the stock before 29 May 2023. Payment date: 29 June 2023. The company is not currently making a profit but it is cash flow positive. Trailing yield: 5.6%. Within top quartile of German dividend payers (4.7%). Higher than average of industry peers (4.4%). Valuation Update With 7 Day Price Move • Mar 15
Investor sentiment deteriorates as stock falls 20% After last week's 20% share price decline to €4.01, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 10x in the Insurance industry in Germany. Total returns to shareholders of 149% over the past three years. Anuncio • Feb 10
Aegon N.V. (ENXTAM:AGN) announces an Equity Buyback for 200 shares. Aegon N.V. (ENXTAM:AGN) announces a share repurchase program. Under the program, the company will repurchase up to €200 million worth of its shares. The purpose of the share repurchase program is to return surplus cash capital to its shareholders. The repurchase program is expected to be completed on or before June 30, 2023. Anuncio • Feb 09
Aegon N.V. Proposes Dividend for 2022 Aegon N.V. Proposed final 2022 dividend of EUR 0.12 per common share to be paid in cash, which brings the full year dividend to EUR 0.23 per common share. Anuncio • Jan 10
Aegon N.V. to Report Fiscal Year 2022 Final Results on Mar 15, 2023 Aegon N.V. announced that they will report fiscal year 2022 final results at 11:00 PM, Central European Standard Time on Mar 15, 2023 Anuncio • Jan 06
Aegon N.V. (ENXTAM:AGN) announces an Equity Buyback for €42.5 million worth of its shares. Aegon N.V. (ENXTAM:AGN) announces a share repurchase program. Under the program, the company will repurchase up to €42.5 million worth of its shares. The purpose of the share repurchase program is to meet its obligations resulting from the share-based compensation plans for senior management. The repurchased shares will be held as treasury shares until they are allocated to the plan participants. The repurchase program is expected to be completed on or before January 30, 2023. Reported Earnings • Nov 16
Third quarter 2022 earnings released: €0.10 loss per share (vs €0.039 loss in 3Q 2021) Third quarter 2022 results: €0.10 loss per share (further deteriorated from €0.039 loss in 3Q 2021). Net loss: €204.0m (loss widened 152% from 3Q 2021). Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Insurance industry in Germany. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings. Reported Earnings • Nov 13
Third quarter 2022 earnings released: €0.10 loss per share (vs €0.039 loss in 3Q 2021) Third quarter 2022 results: €0.10 loss per share (further deteriorated from €0.039 loss in 3Q 2021). Net loss: €204.0m (loss widened 152% from 3Q 2021). Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Insurance industry in Germany. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings. Upcoming Dividend • Aug 16
Upcoming dividend of €0.11 per share Eligible shareholders must have bought the stock before 23 August 2022. Payment date: 21 September 2022. Payout ratio is a comfortable 42% and this is well supported by cash flows. Trailing yield: 4.6%. Within top quartile of German dividend payers (4.5%). In line with average of industry peers (5.1%). Reported Earnings • Aug 12
Second quarter 2022 earnings released Second quarter 2022 results: Net loss: €365.0m (down 144% from profit in 2Q 2021). Over the last 3 years on average, earnings per share has increased by 11% per year and the company’s share price has also increased by 11% per year. Upcoming Dividend • May 26
Upcoming dividend of €0.09 per share Eligible shareholders must have bought the stock before 02 June 2022. Payment date: 06 July 2022. Payout ratio is a comfortable 22% but the company is not cash flow positive. Trailing yield: 3.6%. Lower than top quartile of German dividend payers (4.3%). Lower than average of industry peers (5.0%). Reported Earnings • May 14
First quarter 2022 earnings released: EPS: €0.19 (vs €0.18 in 1Q 2021) First quarter 2022 results: EPS: €0.19 (up from €0.18 in 1Q 2021). Revenue: -€8.45b (down 195% from 1Q 2021). Net income: €383.0m (up 2.4% from 1Q 2021). Over the next year, revenue is expected to shrink by 34% compared to a 20% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth. Reported Earnings • Mar 19
Full year 2021 earnings: EPS in line with expectations, revenues disappoint Full year 2021 results: EPS: €0.78 (up from €0.003 in FY 2020). Revenue: €49.2b (up 1.0% from FY 2020). Net income: €1.61b (up €1.61b from FY 2020). Profit margin: 3.3% (up from 0% in FY 2020). The increase in margin was primarily driven by lower expenses. Revenue missed analyst estimates by 100%. Over the next year, revenue is expected to shrink by 58% compared to a 21% growth forecast for the insurance industry in Germany. Over the last 3 years on average, earnings per share has increased by 2% per year whereas the company’s share price has remained flat. Valuation Update With 7 Day Price Move • Mar 07
Investor sentiment deteriorated over the past week After last week's 16% share price decline to €3.73, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 9x in the Insurance industry in Germany. Total loss to shareholders of 5.3% over the past three years. Reported Earnings • Nov 14
Third quarter 2021 earnings released: €0.039 loss per share (vs €0.20 loss in 3Q 2020) The company reported a decent third quarter result with reduced losses and improved control over expenses, although revenues were weaker. Third quarter 2021 results: Revenue: €7.06b (down 48% from 3Q 2020). Net loss: €81.0m (loss narrowed 80% from 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings. Reported Earnings • Aug 13
Second quarter 2021 earnings released The company reported a decent second quarter result with improved earnings and profit margins, although revenues were weaker. Second quarter 2021 results: Revenue: €18.3b (down 42% from 2Q 2020). Net income: €842.0m (up €1.91b from 2Q 2020). Profit margin: 4.6% (up from net loss in 2Q 2020). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings. Executive Departure • Jun 02
Global CTO & Member of the Management Board has left the company On the 1st of June, Mark Bloom's tenure as Global CTO & Member of the Management Board ended after 5.3 years in the role. We don't have any record of a personal shareholding under Mark's name. A total of 5 executives have left over the last 12 months. Executive Departure • Jun 02
Global Head of Human Resources & Member of the Management Board has left the company On the 1st of June, C. M. Mahieu's tenure as Global Head of Human Resources & Member of the Management Board ended after 10.8 years in the role. We don't have any record of a personal shareholding under C. M.'s name. A total of 5 executives have left over the last 12 months. Upcoming Dividend • Jun 01
Upcoming dividend of €0.06 per share Eligible shareholders must have bought the stock before 07 June 2021. Payment date: 07 July 2021. Trailing yield: 3.1%. Lower than top quartile of German dividend payers (3.2%). Lower than average of industry peers (4.2%). Executive Departure • May 18
CEO of Aegon the Netherlands & Member of the Management Board Maarten Edixhoven has left the company On the 11th of May, Maarten Edixhoven, was replaced as CEO by E. Friese. We don't have any record of a personal shareholding under Maarten's name. A total of 3 executives have left over the last 12 months. Reported Earnings • May 13
First quarter 2021 earnings released: EPS €0.18 (vs €0.61 in 1Q 2020) The company reported a soft first quarter result with weaker earnings and revenues, although profit margins were improved. First quarter 2021 results: Revenue: €9.57b (down 147% from 1Q 2020). Net income: €383.0m (down 70% from 1Q 2020). Profit margin: 4.0% (up from net loss in 1Q 2020). The move to profitability was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 62% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings. Executive Departure • Apr 02
Member of the Management Board and President & CEO of Transamerica Corporation Mark Mullin has left the company On the 31st of March, Mark Mullin, was replaced as CEO by E. Friese. We don't have any record of a personal shareholding under Mark's name. A total of 3 executives have left over the last 12 months. Reported Earnings • Mar 21
Full year 2020 earnings released: EPS €0.022 (vs €0.56 in FY 2019) The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: €51.4b (down 20% from FY 2019). Net income: €45.0m (down 96% from FY 2019). Profit margin: 0.1% (down from 1.8% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings. Is New 90 Day High Low • Mar 03
New 90-day high: €4.21 The company is up 33% from its price of €3.16 on 03 December 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Insurance industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €15.87 per share. Is New 90 Day High Low • Feb 10
New 90-day high: €3.66 The company is up 28% from its price of €2.86 on 11 November 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Insurance industry, which is up 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €8.80 per share. Is New 90 Day High Low • Jan 15
New 90-day high: €3.64 The company is up 49% from its price of €2.44 on 16 October 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Insurance industry, which is up 18% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €9.25 per share. Is New 90 Day High Low • Dec 28
New 90-day high: €3.26 The company is up 49% from its price of €2.18 on 29 September 2020. The German market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Insurance industry, which is up 14% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €7.68 per share. Is New 90 Day High Low • Nov 16
New 90-day high: €2.98 The company is up 24% from its price of €2.39 on 18 August 2020. The German market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Insurance industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €7.48 per share. Valuation Update With 7 Day Price Move • Nov 13
Market bids up stock over the past week After last week's 18% share price gain to €2.90, the stock is trading at a trailing P/E ratio of 6.9x, up from the previous P/E ratio of 5.9x. This compares to an average P/E of 11x in the Insurance industry in Germany. Total return to shareholders over the past three years is a loss of 34%.